Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy
✍ Scribed by C. A. Davie; G. K. Wenning; G. J. Barker; P. S. Tofts; B. E. Kendall; N. Quinn; W. I. McDonald; C. D. Marsden; D. H. Miller
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 677 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract To investigate the diagnostic value of brain magnetic resonance image (MRI) and ^18^F‐fluorodeoxyglucose positron emission tomography (^18^F‐FDG PET) in the differentiation of multiple system atrophy (MSA) from Parkinson's disease (PD). Thirty‐five patients with MSA (23 MSA‐P and 12 MSA
## Abstract Both dopamine D2 receptor (D2R) binding single‐photon emission computed tomography (SPECT) with [^123^I]iodobenzamide (IBZM) and diffusion‐weighted imaging (DWI) have been shown to contribute to the differential diagnosis of patients with the Parkinson variant of multiple system atrophy